Atorvastatin Calcium Tablet
Product Images NDC 68071-3868

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68071-3868). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (3ce77d64 B08e 43b6 A3ab 3aca688f734a 01)

Image (3ce77d64 B08e 43b6 A3ab 3aca688f734a 01)
Chemical structure of atorvastatin calcium, shown with molecular components including rings and side chains, calcium ions (Ca2+), and water molecules (3H2O).*
FDA Label Image

Image (3ce77d64 B08e 43b6 A3ab 3aca688f734a 02)

Image (3ce77d64 B08e 43b6 A3ab 3aca688f734a 02)
A line graph comparing cumulative incidence percentages over 3.5 years for Atorvastatin versus placebo. The solid line represents Atorvastatin, showing a lower cumulative incidence compared to the dashed line representing placebo. The graph includes statistical values for hazard ratio (HR=0.64 with 95% confidence interval 0.50-0.83) and p-value (0.0005).*
FDA Label Image

Image (3ce77d64 B08e 43b6 A3ab 3aca688f734a 03)

Image (3ce77d64 B08e 43b6 A3ab 3aca688f734a 03)
A line graph showing cumulative hazard percentage over time from 0 to 5 years, comparing placebo and atorvastatin groups. The graph illustrates lower cumulative hazard in the atorvastatin group versus placebo, with a labeled hazard ratio (HR) of 0.63 and p-value of 0.001, indicating statistical data from a follow-up study.*
FDA Label Image

Image (3ce77d64 B08e 43b6 A3ab 3aca688f734a 04)

Image (3ce77d64 B08e 43b6 A3ab 3aca688f734a 04)
A Kaplan-Meier curve comparing the time to first major cardiovascular endpoint over 5 years between subjects taking atorvastatin 10 mg and atorvastatin 80 mg. The y-axis represents the percentage of subjects experiencing the event, and the graph shows lower event rates for the 80 mg group compared to the 10 mg group. Hazard ratio and p-value are included on the chart.*
FDA Label Image

Pdp (68071 3868 3)

Pdp (68071 3868 3)
Label for Atorvastatin Calcium 10 mg tablets by NuCare Pharmaceuticals, Inc. The label states #30 tablets, prescription only, and describes the tablets as oval-shaped, white to off-white, with '11' debossed on one side. Manufactured by Graviti Pharmaceuticals Pvt. Ltd., India. Includes warnings, storage instructions, and lot, serial, and expiration placeholders.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.